Ravulizumab for adults with generalized myasthenia gravis: a plain language summary of three studies

Abstract

What is this summary about? Generalized myasthenia gravis (often shortened to gMG) is a rare health condition that causes muscular weakness. This summary gives an overview of three published articles that report the results of research studies of a medicine called ravulizumab, a treatment approved for adults with gMG. These studies are: • The CHAMPION MG study. • The CHAMPION MG extension study. • A study of how the body processes and responds to ravulizumab (known as pharmacokinetics and pharmacodynamics). These studies looked at how effective and safe ravulizumab is for people with gMG.

Keywords

• generalized myasthenia gravis
• gmg
• muscular weakness
• plain language summary
• ravulizumab